Skip to main content
Equibles

Rafferty Asset Management, LLC

Position in MYGN — Myriad Genetics Inc

CIK 1389426 New York, NY
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$478,617
-$47,946 QoQ
Shares Held
83,821
-28.4% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 196 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $85,587,160 across 17 Diagnostics & Research names. MYGN ranks #16 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 40,905 $20,508,130
2 IDXX
Idexx Laboratories Inc /De
 34,084 $17,943,180
3 DHR
Danaher Corp /De/
 69,337 $13,207,311
4 A
Agilent Technologies, Inc.
 31,106 $4,131,809
5 WAT
Waters Corp /De/
 10,809 $4,053,807
6 IQV
Iqvia Holdings Inc.
 18,371 $3,549,644
7 NTRA
Natera, Inc.
 12,749 $3,460,716
8 MTD
Mettler Toledo International Inc/
 2,223 $2,839,904

All Filings in MYGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $478,617 83,821
2026-03-31 $526,563 117,014
2025-12-31 $917,758 149,229
2025-09-30 $815,435 112,785
2025-06-30 $599,753 112,948
2025-03-31 $1,302,151 146,804
2024-12-31 $2,277,751 166,138
2024-09-30 $3,025,170 110,448
2024-06-30 $2,285,933 93,456
2024-03-31 $5,313,007 249,203
2023-12-31 $3,280,576 171,399
2023-09-30 $3,344,083 208,484
2023-06-30 $4,549,121 196,252
2023-03-31 $3,945,406 169,841
2022-12-31 $2,993,891 206,333
2022-09-30 $3,268,098 171,284
2022-06-30 $1,976,932 108,802
2022-03-31 $3,300,872 130,987
2021-12-31 $4,883,047 176,922
2021-09-30 $3,027,833 93,770
2021-06-30 $2,683,028 87,738
2021-03-31 $3,268,868 107,352
2020-12-31 $404,909 20,481
2020-09-30 $1,050,345 80,548
2020-06-30 $601,450 53,038
2020-03-31 $144,502 10,098